QuickView for stage I lung adenocarcinoma (biogroup)

1. L1000 CMAP - T-cell ALL JURKAT cells treated with small molecule perturbagens
2. Macrophages infected with Legionella pneumophila wildtype or isogenic mutant with ankyrin H deletion
3. Macrophage gene expression profiles in response to LPS or E. coli - the role of MyD88
4. Bone marrow- and peritoneal-derived mouse macrophages in resonse to a timecourse of LPS treatment
5. PBMCs of healthy donors treated with heat killed group A streptococcus and/or hydroxychloroquine

There were no matches for stage I lung adenocarcinoma

1. ctDNA-MRD Based Adjuvant Targeted Therapy for EGFR Positive Stage I Lung Adenocarcinomas
2. Deep Learning Signature for Predicting the Novel Grading System of Clinical Stage I Lung Adenocarcin…
3. Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung A…
4. Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With…
5. Postoperative Pembrolizumab for the Patients Who Have Solid Predominant or Micropapillary Lung Adeno…